Related Experiment Videos
The pathogenesis of cutaneous fibrosis
1Department of Dermatology at UCSF and Scleroderma Research Center at UCSF and Stanford, San Francisco, CA 94143-0517, USA.
Seminars in Cutaneous Medicine and Surgery
|March 25, 1998
Summary
Cutaneous fibrosis, seen in scleroderma, involves fibroblast activation. This review explores molecular triggers and proposes a model for persistent fibroblast activation in scleroderma, even without external factors.
Area of Science:
- Dermatology
- Fibrosis Research
- Molecular Biology
Background:
- Cutaneous fibrosis is a hallmark of disorders like keloids, hypertrophic scars, and scleroderma.
- These conditions share dysregulated connective tissue metabolism, specifically activated dermal fibroblasts.
Purpose of the Study:
- To examine molecular events causing fibroblast activation in scleroderma.
- To propose a novel model for sustained fibroblast activation in scleroderma.
Main Methods:
- Review of molecular events in scleroderma.
- Analysis of fibroblast activation pathways.
Main Results:
- Identified key molecular events driving fibroblast activation in scleroderma.
- Proposed a model for persistent fibroblast activation.
Conclusions:
- Fibroblast activation is central to scleroderma pathogenesis.
- The proposed model offers insights into the persistence of fibroblast activation in scleroderma.